Autonomic Dysreflexia in SCI (T6 or Above): Neurogenic Bladder Management When Systolic Blood Pressure Stays Elevated After Initial Measures
Autonomic dysreflexia (AD) is a medical emergency specific to patients with spinal cord injury at the neurologic level T6 or above. When standard immediate measures do not return systolic blood pressure to baseline, a defined pharmacological next step is required.
Clinical Scenario
This protocol applies to patients with neurogenic bladder in the context of AD and SCI at the neurologic level T6 or above, when systolic blood pressure exceeds 150 mm Hg or is more than 20 mm Hg above the patient's individual baseline. Patients presenting with persistent classic symptoms — flushing, sweating, headache, blurry vision, and a sense of impending doom — are not adequately managed by conservative measures alone.
When the First Step Has Not Worked
Standard first-line management — terminating the inciting procedure, immediately draining the urinary bladder, placing the patient upright in a wheelchair, loosening tight clothing and constrictive devices, and continuing hemodynamic monitoring — is the expected initial response. This protocol applies when those measures have not achieved their primary goal: systolic blood pressure returning to baseline with stable vital signs.
Next-Step Approach
When first-line management does not adequately control blood pressure, pharmacological intervention with a vasodilatory agent is the established next step — nitrates represent the most commonly used medication class for refractory AD-associated blood pressure elevation. The complete protocol specifies agent selection, application considerations, and monitoring requirements.
References
AD is a medical emergency specific to patients with SCI at the neurologic level T6 or above.
Patients with a systolic blood pressure greater than 150 mm Hg and/or 20 mm Hg above baseline who exhibit persistent classic symptoms such as flushing, sweating, headache, blurry vision, and a sense of impending doom are not adequately managed.
In general, nitrates are the most commonly used medication to manage refractory AD associated blood pressure elevation because they have a direct relaxant effect on vascular smooth muscles, leading to dilation of coronary vessels and peripheral veins.
The topical application of 1 to 2 inches of 2% nitroglycerine paste on the skin, above the level of the spinal cord lesion, is effective and can be easily removed in order to minimize the subsequent risk of hypotension once the hypertensive crisis subsides.
Alternatively, nifedipine, a dihydropyridine, voltage-sensitive calcium channel blocker, can be used.
When it is administered in immediate-release sublingual form (10 mg capsules), it exerts coronary and peripheral vasodilator properties.
View source ↗